It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) experienced cardiac arrest.Boston scientific technical services (ts) was consulted and upon review, it was noted that the event started as a rapid atrial fibrillation (af) that progressed into the ventricular tachycardia (vt) zone under the detection rate which failed to convert the episode.The device delivered anti-tachycardia pacing (atp) and an electric shock that successfully converted the rhythm.Reprogramming options were discussed, and further testing was recommended for device optimization.Additional information from the field representative confirmed the physician suspected the device undersensed the ventricular fibrillation (vf).No additional adverse patient effects were reported.At this time, this device system remains in service.
|